1.New concept of treatment guideline of dyslipidemia.
Journal of the Korean Medical Association 2016;59(5):349-351
No abstract available.
Dyslipidemias*
2.Treatment of dyslipidemia.
Korean Journal of Medicine 2003;64(4):484-491
No abstract available.
Dyslipidemias*
3.Validity of total cholesterol testing in detecting dyslipidemia.
Soo Young KIM ; Seung Pil JUNG
Journal of the Korean Academy of Family Medicine 1993;14(10):653-660
No abstract available.
Cholesterol*
;
Dyslipidemias*
4.2018 Guidelines for the Management of Dyslipidemia in Korea
Eun Jung RHEE ; Hyeon Chang KIM ; Jae Hyeon KIM ; Eun Young LEE ; Byung Jin KIM ; Eun Mi KIM ; YoonJu SONG ; Jeong Hyun LIM ; Hae Jin KIM ; Seonghoon CHOI ; Min Kyong MOON ; Jin Oh NA ; Kwang Yeol PARK ; Mi Sun OH ; Sang Youb HAN ; Junghyun NOH ; Kyung Hee YI ; Sang Hak LEE ; Soon Cheol HONG ; In Kyung JEONG ;
Journal of Lipid and Atherosclerosis 2019;8(2):78-131
No abstract available.
Dyslipidemias
;
Korea
5.Investigation of regulative effect of an traditional herb prescription (Ban ha Bach truat Thien ma thang) for dyslipidemia
Journal of Practical Medicine 2000;392(12):16-18
The study given an insight on the similarity in dyslipidemia syndrome between Western medicine and East medicine. 60 patients with dyslipidemia examined from December 1997 to July 1998 were investigated. Results suggested that the herb extract combination was an effect treatment for wind-phlegm form of dyslipidemia. It reduced triglycerid level by 31.5%, total cholesterol by 16%, LDL-C by 20.2% and apoprotein B by 16.7%, increased HDL-C by 19.8% and apoprotein by 14.1%.
Dyslipidemias
;
Medicine, Herbal
6.Dyslipidemia on patients with cerebrovascular stroke
Journal of Practical Medicine 2002;435(11):27-28
61 patients (age 20-59 years) treating in the Department for Internal Medicine were investigated using descriptive method. These patients have not any endocrine disease. There are significant difference in serum lipid and lipoprotein levels between patients with cerebrovascular stroke and general population. Common types of dyslipidemia are that can cause risk for developing arteriosclerosis, in which type IV is 59.02%.
Cerebrovascular Accident
;
Dyslipidemias
7.Dyslipidemia during treatment of nephrotic syndrome at Hue Central Hospital
Journal of Practical Medicine 2002;435(11):45-47
Dyslipidemia is very common in nephrotic syndrome, but in clinical practice this problem is not much interested in, although hyperlipidemia can make dangerous complications for the patients. This study examined the variety of dyslipidemia after steroid treatment in patients with nephrotic syndrome but without renal failure. We studied on 40 patients with nephrotic syndrome at HuÕ Central Hospital and found that before treatment, total cholesterol and LDL concentrations are high. After two-week therapy, these concentrations decreased but insignificantly. After four-week therapy, total cholesterol and LDL concentrations decreased, HDL concentration increased. There was significant difference in comparison with the pre-treated concentrations (p<0.05).
Nephrotic Syndrome
;
Dyslipidemias
;
therapy
8.Dyslipidemia in Preeclampsia.
Korean Journal of Perinatology 2002;13(3):241-246
No abstract available.
Dyslipidemias*
;
Pre-Eclampsia*
9.Drug Therapy of Dyslipidemia.
Journal of the Korean Medical Association 1998;41(12):1277-1286
No abstract available.
Drug Therapy*
;
Dyslipidemias*
Result Analysis
Print
Save
E-mail